Tian An MedicareCOLRF 45 Return-on-Tangible-Equity is -4.34% as of Dec. 2025. GuruFocus rates COLRF with a GF Score™ of 45/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 582 Healthcare Providers & Services companies, Tian An Medicare ranks worse than 76.12% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Tian An Medicare's annualized net income for the quarter that ended in Dec. 2025 was $-10.0 Mil. Tian An Medicare's average shareholder tangible equity for the quarter that ended in Dec. 2025 was $229.8 Mil. Therefore, Tian An Medicare's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was -4.34%.
The historical rank and industry rank for Tian An Medicare's Return-on-Tangible-Equity or its related term are showing as below:
COLRF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -43.67 Med: -5.02 Max: 1.97
Current: -1.49
During the past 13 years, Tian An Medicare's highest Return-on-Tangible-Equity was 1.97%. The lowest was -43.67%. And the median was -5.02%.
COLRF's Return-on-Tangible-Equity is ranked worse than 76.12% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs COLRF: -1.49
Tian An Medicare (OTCPK:COLRF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Tian An Medicare Return-on-Tangible-Equity Related Terms
Tian An Medicare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Tian An Medicare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COLRF vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Tian An Medicare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tian An Medicare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Tian An Medicare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -4.34% mean?
Tian An Medicare (COLRF) has a Return-on-Tangible-Equity of -4.34% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Tian An Medicare and its competitors. According to the industry distribution chart, Tian An Medicare ranks #443 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 76.1%.
Is Tian An Medicare's Return-on-Tangible-Equity too high?
Tian An Medicare's current Return-on-Tangible-Equity is -4.34%. Based on the distribution chart, Tian An Medicare ranks #443 out of 582 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Tian An Medicare has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #443 out of 582 companies for Return-on-Tangible-Equity. This places Tian An Medicare in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Tian An Medicare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current Return-on-Tangible-Equity is -4.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current Return-on-Tangible-Equity of -4.34%. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current Return-on-Tangible-Equity is -4.34%. Tian An Medicare's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current Return-on-Tangible-Equity is -4.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tian An Medicare (COLRF) Overvalued in 2026?
Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued.
The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.
Key valuation signals for COLRF:
Return-on-Tangible-Equity: -4.34%
GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
45GF Score
Get the complete analysis for COLRF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COLRF has been successfully added to your 
